Guardian Pharmacy Services GRDN

NYSE · Retail-Drug Stores And Proprietary Stores · $3.1B
Every report since 2024 →

No closes on file for GRDN yet.

Data provided by Databento (end of day). Next close = the first close after a story against the close before it; official daily closes only, not a call, not advice.

The numbers

fiscal 2025, as filed with the SEC · 66-metric EOD snapshot via Databento
Market cap$3.1B
Enterprise value$3.1B
Revenue$1.4B +17.9%
Gross margin20.2%
ROIC31.8%
Modern Valuation (EOD)
Market Cap$3.1B
Enterprise Value$3.1B
EV / True FCF—
EV / FCF—
EV / Gross Profit10.44
EV / EBIT42.04
EV / Sales2.11
P / E (GAAP)63.42
P / FCF—
P / Oper. CF31.14
P / Book14.32
Owner & Cash Yields
True FCF Yield—
FCF Yield—
Owner Earn. Yield—
Earnings Yield1.6%
Shareholder Yield—
Buyback Yield—
Dividend Yield—
Dividend / sh—
Payout Ratio—
FCF / sh—
EPS (diluted)—
Compounder & Returns
Rule of 40—
ROIC31.8%
Cash ROIC (CROIC)—
GP / Assets70.9%
ROE22.6%
ROA11.9%
Gross Margin20.2%
Oper. Margin5.0%
Net Margin3.4%
FCF Margin—
True FCF Margin—
Quality & Dilution
Cash Conversion—
Accrual Ratio−12.4%
SBC % of FCF—
SBC % of Rev1.0%
Reinvest. Rate—
Sales Growth Y/Y+17.9%
Sales 3Y CAGR—
EPS Growth Y/Y—
FCF Growth Y/Y—
FCF 3Y CAGR—
Share Change Y/Y—
Balance Sheet & Scale
Revenue (FY)$1.4B
Gross Profit (FY)$292.7M
Oper. Income (FY)$72.7M
GAAP Net Income$49.2M
True FCF (ex-SBC)—
Cash & Equiv$65.6M
Total Debt—
Net Cash (Debt)$65.6M
Net Cash % MCap+2.1%
Debt / FCF (yrs)0.0y
Current Ratio1.38
Price & Technicals (EOD)
Perf Week—
Perf Month—
Perf Quarter—
Perf Half Y—
Perf YTD—
SMA 20 Dist—
SMA 50 Dist—
SMA 100 Dist—
Window High—
Window Low—
RSI (14) · Vol—
Income Distribution & Cash Flow ConversionHow every dollar of GRDN revenue flows through cost of goods, operating expenses, taxes, GAAP net income, and dilution-adjusted free cash flow
REVENUE · 100%$1.4BGROSS PROFIT · 20.2%$292.7MCOST OF REV · 79.8%$1.2BOPER. INCOME · 5.0%$72.7MOPEX · 15.2%$220.0M · SG&A $220.0MNET INCOME · 3.4%$49.2M
Where Every $100 of Revenue Goes (FY2025)
Cost of Revenue (COGS)$1.2B ($79.8 / $100)
SG&A & Other OpEx$220.0M ($15.2 / $100)
Tax & Non-Operating$23.5M ($1.6 / $100)
Net Profit Kept$49.2M ($3.4 / $100)
Earnings Quality: GAAP Profit → True Owner Cash (FY2025)
GAAP Net Income$49.2M (3.4% margin)
Operating Cash Flow (OCF)$100.3M(6.9% of rev)
Less: Capital Expenditures—
Standard Free Cash Flow (FCF)—
Less: Stock-Based Comp (SBC)−$13.8M
True FCF (Owner Cash ex-SBC)—

Operating leverage — margins

GrossOperatingNet
0%40%80%20%5%3%FY24FY25
Unlocked SEC EDGAR Accounting Statements (USD)All 3 statements · Common-size (% of Revenue / Assets) · YoY growth · Tap any core row to explain
Line Item (USD)FY2024FY2025YoY ΔCAGRTrend
Income Statement
Cost of Revenue (COGS)$984.0M$1.2B+17.5%+17.5%
Selling, General & Admin (SG&A)$307.3M$220.0M−28.4%−28.4%
Total Operating Expenses$307.3M$220.0M−28.4%−28.4%
Interest Expense$3.3M$665,000−79.7%−79.7%
Income Tax Expense$4.6M$24.5M+437.0%+437.0%
Balance Sheet
Cash & Equivalents$4.7M$65.6M+1308.1%+1308.1%
Inventory$40.5M$43.4M+6.9%+6.9%
Total Current Assets$152.0M$221.6M+45.8%+45.8%
Total Assets$320.8M$412.7M+28.6%+28.6%
Total Current Liabilities$144.1M$160.7M+11.5%+11.5%
Total Debt (Short + Long Term)$0$0——
Total Liabilities$170.8M$194.7M+14.0%+14.0%
Stockholders' Equity$150.0M$217.9M+45.3%+45.3%
Net Cash / (Net Debt)$4.7M$65.6M+1308.1%+1308.1%
Invested Capital$145.3M$152.3M+4.8%+4.8%
Cash Flow & Capital Allocation
Depreciation & Amortization (D&A)$19.8M$22.3M+13.0%+13.0%
Stock-Based Compensation (SBC)$131.5M$13.8M−89.5%−89.5%

Fundamentals, income distribution and multi-year statements from SEC EDGAR filings (public domain). Valuation multiples, performance and technicals computed from Databento 1D EOD closes. For information only, not investment advice.

On the Wire

what GRDN did at the next close after each story

No Wire story has named GRDN yet.

The Wire at 7 AM ET, free. Top stories with a bull and a bear case on each, every morning. No account needed.